SCHEMBL26075695

SCHEMBL26075695

Cc1cc(-c2ccc(-c3ccc(N(C)C)cc3)cn2)nc2ccc(C(F)(F)F)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 2/20 0.47
▸ MAPT P10636 1/20 0.44
▸ AURKA O14965 1/20 0.40
▸ CTSC P53634 1/20 0.39
▸ MCHR1 Q99705 1/20 0.39
▸ DHODH Q02127 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ DGAT1 O75907 2/20 0.38
▸ NPBWR1 P48145 2/20 0.38
▸ APP P05067 4/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ TCF4 P15884 1/20 0.36
▸ CTNNB1 P35222 1/20 0.36
▸ DHFR P00374 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075698 0.85 KIF11 (0.47) KDM1AMCHR1DHODHDGAT1NPBWR1
SCHEMBL23590037 0.85 DHODH (0.45) KDM1AMAPTDHODHMEN1ALDH1A1
SCHEMBL26075701 0.83 MCHR1 (0.40) MAPTMCHR1DHODHDGAT1NPBWR1
SCHEMBL26075691 0.83 ACP1 (0.42) MAPTDHODHPDGFRBDGAT1NPBWR1
SCHEMBL26075688 0.82 ACP1 (0.37) MCHR1DHODHDGAT1NPBWR1KCNH2
SCHEMBL26075703 0.80 CBFB (0.43) MCHR1DHODHDGAT1NPBWR1APP
SCHEMBL26075419 0.79 KDM1A (0.46) KDM1AMAPTMCHR1DHODHAPP
SCHEMBL26075603 0.76 KDM1A (0.44) KDM1AMAPTAURKAMCHR1DHODH
SCHEMBL26075693 0.75 DGAT1 (0.42) MAPTMCHR1DGAT1MEN1ALDH1A1
SCHEMBL26074092 0.74 APP (0.49) KDM1ADHODHPDGFRBPDGFRAAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD KDM1A 919/4885MAPT 2689/4885AURKA 3217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback